Drug Type Small molecule drug |
Synonyms Atorvastatin/glimepiride, Glimepiride/atorvastatin |
Action inhibitors, blockers, modulators |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), KATP channels blockers, SUR modulators(Sulfonylurea receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC66H76CaF2N4O13 |
InChIKeyHIZONJHAVINWOX-NIJVSVLQSA-N |
CAS Registry344423-98-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 3 | Malaysia | 01 Dec 2011 | |
| Diabetes Mellitus, Type 2 | Phase 3 | Mexico | 01 Dec 2011 | |
| Diabetes Mellitus, Type 2 | Phase 3 | Philippines | 01 Dec 2011 | |
| Diabetes Mellitus, Type 2 | Phase 3 | Russia | 01 Dec 2011 | |
| Diabetes Mellitus, Type 2 | Phase 3 | South Korea | 01 Dec 2011 | |
| Diabetes Mellitus, Type 2 | Phase 3 | Thailand | 01 Dec 2011 |





